Mati Therapeutics Inc. — Form D

Mati Therapeutics Inc. of AUSTIN, TX, a company, filed a Form D exempt-offering notice with the SEC on 2025-10-08. The offering totals $10.5M, of which $9.9M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (29)

Showing 25 of 29 people.

NameRoleLocation
Robert ButchofskyDirectorAustin, TX
Christopher MullerDirectorAustin, TX
Joseph Tortorice IIIDirectorAustin, TX
Deepank UtkhedeDirectorAustin, TX
Robert ButchofskyExecutive OfficerAustin, TX
Christopher MullerExecutive OfficerAustin, TX
Cameron NelsonExecutive OfficerAustin, TX
Robert ButchofskyRelated PersonAustin, TX
Christopher MullerRelated PersonAustin, TX
Cameron NelsonRelated PersonAustin, TX
Joseph Tortorice IIIRelated PersonAustin, TX
Robert Lee Butchofsky IIDirectorAustin, TX
Robert Lee Butchofsky IIExecutive OfficerAustin, TX
Cameron Lee NelsonExecutive OfficerVancouver, A1
Christopher Lee MullerDirectorFoothill Ranch, CA
Christopher Lee MullerExecutive OfficerFoothill Ranch, CA
Deepank Lee UtkhedeDirectorSurrey, A1
Deepank Lee UtkhedeExecutive OfficerSurrey, A1
Ken JonesRelated PersonAustin, TX
Peter McDonnellRelated PersonAustin, TX
Jim MazzoRelated PersonAustin, TX
Deepank Lee UtkedeDirectorAustin, TX
Deepank Lee UtkedeExecutive OfficerAustin, TX
Chris Lee MullerDirectorAustin, TX
Chris Lee MullerExecutive OfficerAustin, TX

Other filings by this issuer (6)

FiledFormOfferingSold
2026-07-02D/A$4.9M$2.6M
2025-09-23D$2.2M$2.2M
2019-05-24D$1.5M$165K
2018-10-16D$1.2M$50K
2014-10-10D$13.8M$150K
2013-04-15D$10.0M$1.3M

More